Novo Holdings A/S

Company	Share, %
VectivBio Holding AG	5.75
Galecto, Inc.	5.42
Edgewise Therapeutics, Inc.	5.05
Zenas BioPharma, Inc. Common Stock	3.73
4D Molecular Therapeutics, Inc.	3.5
IO Biotech, Inc.	3.49
Valneva SE	2.72
Enliven Therapeutics, Inc.	2.4